AstraZeneca Newsroom

US, UK to Seek Preferential Treatment on Pharmaceutical Tariffs

MT Newswires08:47 ET

AstraZeneca Announces Statistically Significant Results From POTOMAC Trial

TipRanks06:44 ET

Express News | AstraZeneca's High-Level Results From POTOMAC Phase 3 Trial Showed One Year Of Treatment With Imfinzi (Durvalumab) Plus Standard-of-care Bacillus Calmette-guérin (BCG) Induction And Maintenance Therapy Demonstrated Improvement In Disease-Free...

Benzinga05:42 ET

AstraZeneca Breaks Ground on New Small Molecule Drug Factory in Wuxi

China Daily03:14 ET

AstraZeneca's Imfinzi Regimen Extends Disease-free Survival in Late-stage Bladder Cancer Trial

MT Newswires02:51 ET

Top Gap Ups and Downs on Thursday: AZN, MELI, APP and More

Moomoo News18:00 ET · Markets

Unusual Options Activity: MSTR, TECK and Others Attract Market Bets, MSTR V/OI Ratio Reaches 136.4

Moomoo News16:30 ET

AstraZeneca Call Volume Above Normal and Directionally Bullish

TipRanks15:31 ET

FDA to Speed up AI Rollout to Accelerate Drug Reviews

Seeking Alpha14:53 ET

European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT NewswiresMay 8 11:19 ET

Trump Says U.K. Trade Deal Is First of Many. It Will Only Get Harde

Barron'sMay 8 09:12 ET

AstraZeneca, Daiichi's Enhertu Shows PCR Rate Improvement in Breast Cancer Trial

Yahoo FinanceMay 8 05:37 ET

Tariffs News: Trump Flags 'Major Trade Deal.' Why a U.K. Breakthrough Matters. -- Barrons.com

Barron'sMay 8 05:14 ET

AstraZeneca (LSE:AZN) Reports Positive Phase 3 Trial Results For Breast Cancer Treatment

Yahoo FinanceMay 7 14:02 ET

AstraZeneca And Daiichi Sankyo's ENHERTU Followed By THP Shows Improved Safety Profile Vs. Standard Of Care

BenzingaMay 7 07:12 ET

AstraZeneca Reports Results From DESTINY-Breast11 Trial

TipRanksMay 7 05:26 ET

AstraZeneca And Daiichi Sankyo's ENHERTU Achieves Significant PCR Gains With Improved Safety Profile In Early HER2 Positive Breast Cancer Patients

BenzingaMay 7 02:50 ET

Trump wants to impose tariffs on Pharmaceuticals: Pharmaceutical companies are busy stockpiling, and the import volume in the USA surged in March.

① The volume of Pharmaceutical imports in the USA surged in March, as pharmaceutical companies stockpiled products in anticipation of potential tariffs; ② A report released by the US Department of Commerce on Tuesday showed that the total value of Pharmaceutical imports in March exceeded 50 billion USD, equivalent to 20% of the total Pharmaceutical imports for the entire year of 2024.

cls.cnMay 6 20:41 ET

Tempus AI Raises Revenue Guidance to $1.25B for 2025, Supported by New $200M AstraZeneca Deal

Seeking AlphaMay 6 20:18 ET

Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers

Barron'sMay 6 16:57 ET